Source: Benzinga

Organigram: Organigram Shares Jump On Q1 Print, Cannabis Company Doubles Net Revenue

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) released first-quarter financial results Tuesday, reporting net revenue of CA$25.2 million ($19.3 million), up 102% year-over-year from $12.4 million.The company achieved positive adjusted EBITDA in the quarter of CA$4.9 million versus adjusted EBITDA of CA$6.8 million in the first quarter of 2019. Organigram's net loss from continuing operations was CA$0.9 million or CA$0.006 per share on a diluted basis versus net income of CA$29.5 million or CA$0.195 per share in the first quarter of fiscal 2019.Benzinga's Cannabis Capital Conference returns to Miami with North ...Full story available on

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue


Gregory Engel's photo - CEO of Organigram


Gregory Engel

CEO Approval Rating


Organigram is a producer and marketer of medical cannabis for patients and physicians.

Organigram's headquarters is locat...
Read more